FFCP PHASE1:Hg19::chr1:75045223..75045244,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport= | |||
|DPIdataset=robust | |||
|EntrezGene=127254 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=25346 | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=202bp_to_ENST00000433746_5end | |||
|coexpression_cluster_id=C156 | |||
|description=CAGE_peak_13_at_C1orf173_5end | |||
|id=chr1:75045223..75045244,- | |||
|ontology_enrichment_celltype=CL:0000842!5.08e-32!3;CL:0000224!3.36e-24!4;CL:0000080!2.34e-16!6;CL:0000623!3.22e-15!3;CL:0000825!3.22e-15!3;CL:0000946!2.63e-12!1;CL:0000786!2.63e-12!1;CL:0000980!2.63e-12!1;CL:0000838!5.12e-07!52;CL:0000542!7.09e-07!53;CL:0000051!7.09e-07!53;CL:0000785!8.93e-07!2;CL:0000955!8.93e-07!2;CL:0000818!8.93e-07!2;CL:0000954!8.93e-07!2;CL:0000816!8.93e-07!2 | |||
|ontology_enrichment_celltype_v019=CL:0000946;1.23e-66;1!CL:0000786;1.23e-66;1!CL:0000945;3.75e-12;24 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,1.23e-66,1;CL:0000786,1.23e-66,1;CL:0000980,1.23e-66,1;CL:0000785,3.61e-34,2;CL:0000955,3.61e-34,2;CL:0000818,3.61e-34,2;CL:0000954,3.61e-34,2;CL:0000816,3.61e-34,2;CL:0000817,2.62e-23,3;CL:0000945,3.75e-12,24;CL:0000826,3.75e-12,24 | |||
|ontology_enrichment_development_v019=CL:0000954;3.61e-34;2!UBERON:0009117;6.56e-08;10!UBERON:0005564;6.56e-08;10 | |||
|ontology_enrichment_disease=DOID:2355!2.93e-12!1;DOID:74!9.44e-07!2 | |||
|ontology_enrichment_disease_v019=DOID:2355;2.39e-66;1!DOID:74;5.04e-34;2!DOID:1287;8.69e-18;4!DOID:0060058;6.13e-08;10 | |||
|ontology_enrichment_disease_v019_2=DOID:2355,2.39e-66,1;DOID:74,5.04e-34,2;DOID:1287,8.69e-18,4;DOID:0060058,6.13e-08,10 | |||
|ontology_enrichment_uberon=UBERON:0001301!7.76e-12!1;UBERON:0007190!1.47e-11!1;UBERON:0002372!1.63e-11!1;UBERON:0001961!1.63e-11!1;UBERON:0001744!1.63e-11!1;UBERON:0001735!1.63e-11!1;UBERON:0001882!1.81e-11!1;UBERON:0005403!1.81e-11!1;UBERON:0003135!2.45e-09!11;UBERON:0000200!8.41e-08!6;UBERON:0000178!7.35e-07!15;UBERON:0000179!7.35e-07!15;UBERON:0000463!7.35e-07!15 | |||
|ontology_enrichment_uberon_v019=UBERON:0000473;1.47e-09;8!UBERON:0003135;2.63e-07;11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000473,1.47e-09,8;UBERON:0003135,2.63e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.651083453856419,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.196468613246569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.394061520403854,0,0.256686072559497,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206768026122887,0.215714200818617,0.106727557803444,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.123084805461069,0,0,0,0,0,0,0,0,0.0927680981618513,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.17472666824203,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.21758661849981,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.122026264901963,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0642292250964595,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0675375846183947,0,0,0,0,0,0,0,0,0,0,0,0,0.0887023701626388,12.3300366684684,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.833565680400634,1.33982065078089,0,0,0,0,0,0,0,0,0,0,0,0.0673520530145875,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p13@C1orf173 | |||
}} |
Revision as of 19:06, 10 January 2014
Short description: | p13@C1orf173 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_13_at_C1orf173_5end |
Coexpression cluster: | C156_plasma_splenic_hereditary_B_large_xeroderma_b |
Association with transcript: | 202bp_to_ENST00000433746_5end |
EntrezGene: | C1orf173 |
HGNC: | 25346 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 1.23e-66 | 1 |
plasma cell | 1.23e-66 | 1 |
plasmablast | 1.23e-66 | 1 |
mature B cell | 3.61e-34 | 2 |
pre-B-II cell | 3.61e-34 | 2 |
transitional stage B cell | 3.61e-34 | 2 |
small pre-B-II cell | 3.61e-34 | 2 |
immature B cell | 3.61e-34 | 2 |
precursor B cell | 2.62e-23 | 3 |
lymphocyte of B lineage | 3.75e-12 | 24 |
pro-B cell | 3.75e-12 | 24 |
Ontology term | p-value | n |
---|---|---|
testis | 1.47e-09 | 8 |
male reproductive organ | 2.63e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
anemia | 2.39e-66 | 1 |
hematopoietic system disease | 5.04e-34 | 2 |
cardiovascular system disease | 8.69e-18 | 4 |
lymphoma | 6.13e-08 | 10 |